122 related articles for article (PubMed ID: 15470032)
1. E2f1 mutation induces early onset of diabetes and Sjögren's syndrome in nonobese diabetic mice.
Salam MA; Matin K; Matsumoto N; Tsuha Y; Hanada N; Senpuku H
J Immunol; 2004 Oct; 173(8):4908-18. PubMed ID: 15470032
[TBL] [Abstract][Full Text] [Related]
2. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
Matsui-Inohara H; Uematsu H; Narita T; Satoh K; Yonezawa H; Kuroda K; Ito T; Yoneda S; Kawarai T; Sugiya H; Watanabe H; Senpuku H
Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
[TBL] [Abstract][Full Text] [Related]
3. E2F1 and E2F2 are differentially required for homeostasis-driven and antigen-induced T cell proliferation in vivo.
DeRyckere D; DeGregori J
J Immunol; 2005 Jul; 175(2):647-55. PubMed ID: 16002659
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.
Rapoport MJ; Jaramillo A; Zipris D; Lazarus AH; Serreze DV; Leiter EH; Cyopick P; Danska JS; Delovitch TL
J Exp Med; 1993 Jul; 178(1):87-99. PubMed ID: 8315397
[TBL] [Abstract][Full Text] [Related]
5. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG
J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321
[TBL] [Abstract][Full Text] [Related]
6. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.
Cha S; Brayer J; Gao J; Brown V; Killedar S; Yasunari U; Peck AB
Scand J Immunol; 2004 Dec; 60(6):552-65. PubMed ID: 15584966
[TBL] [Abstract][Full Text] [Related]
7. Role of cell cycle regulator E2F1 in regulating CD8 T cell responses during acute and chronic viral infection.
Gao X; Tewari K; Svaren J; Suresh M
Virology; 2004 Jul; 324(2):567-76. PubMed ID: 15207641
[TBL] [Abstract][Full Text] [Related]
8. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
Kern J; Drutel R; Leanhart S; Bogacz M; Pacholczyk R
PLoS One; 2014; 9(11):e112467. PubMed ID: 25379761
[TBL] [Abstract][Full Text] [Related]
9. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
Kim D; Kim JY; Jun HS
Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
[TBL] [Abstract][Full Text] [Related]
10. Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice.
Iglesias A; Murga M; Laresgoiti U; Skoudy A; Bernales I; Fullaondo A; Moreno B; Lloreta J; Field SJ; Real FX; Zubiaga AM
J Clin Invest; 2004 May; 113(10):1398-407. PubMed ID: 15146237
[TBL] [Abstract][Full Text] [Related]
11. E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis.
Zhu JW; Field SJ; Gore L; Thompson M; Yang H; Fujiwara Y; Cardiff RD; Greenberg M; Orkin SH; DeGregori J
Mol Cell Biol; 2001 Dec; 21(24):8547-64. PubMed ID: 11713289
[TBL] [Abstract][Full Text] [Related]
12. Role of gene E2f1 in susceptibility to bacterial adherence of oral streptococci to tooth surfaces in mice.
Matsumoto N; Salam MA; Watanabe H; Amagasa T; Senpuku H
Oral Microbiol Immunol; 2004 Aug; 19(4):270-6. PubMed ID: 15209999
[TBL] [Abstract][Full Text] [Related]
13. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
14. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
[TBL] [Abstract][Full Text] [Related]
15. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection.
Zhu JW; DeRyckere D; Li FX; Wan YY; DeGregori J
Cell Growth Differ; 1999 Dec; 10(12):829-38. PubMed ID: 10616908
[TBL] [Abstract][Full Text] [Related]
16. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity.
Murga M; Fernández-Capetillo O; Field SJ; Moreno B; Borlado LR; Fujiwara Y; Balomenos D; Vicario A; Carrera AC; Orkin SH; Greenberg ME; Zubiaga AM
Immunity; 2001 Dec; 15(6):959-70. PubMed ID: 11754817
[TBL] [Abstract][Full Text] [Related]
17. Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome.
Robinson CP; Brayer J; Yamachika S; Esch TR; Peck AB; Stewart CA; Peen E; Jonsson R; Humphreys-Beher MG
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7538-43. PubMed ID: 9636185
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.
Gregori S; Giarratana N; Smiroldo S; Adorini L
J Immunol; 2003 Oct; 171(8):4040-7. PubMed ID: 14530324
[TBL] [Abstract][Full Text] [Related]
19. Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjögren's syndrome.
Humphreys-Beher MG; Hu Y; Nakagawa Y; Wang PL; Purushotham KR
Adv Exp Med Biol; 1994; 350():631-6. PubMed ID: 8030546
[No Abstract] [Full Text] [Related]
20. Role of CD4+CD45RA+ T cells in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse.
Sempé P; Ezine S; Marvel J; Bédossa P; Richard MF; Bach JF; Boitard C
Int Immunol; 1993 May; 5(5):479-89. PubMed ID: 8318452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
